Orrön Energy AB
Orrön Energy AB’s Nomination Committee
Orrön Energy AB’s Nomination Committee
Orrön Energy AB (“Orrön Energy”) is pleased to announce the composition of the Nomination Committee for the 2026 Annual General Meeting (“AGM”) to be held on 1 April 2026.
The Nomination Committee has been formed with the following members:
- Aksel Azrac (Nemesia S.à.r.l.)
- Richard Ollerhead (JNE Partners LLP)
- Sussi Kvart (Handelsbanken Fonder AB)
At the Nomination Committee’s first meeting, Aksel Azrac was elected as Chair of the Nomination Committee.
The Nomination Committee shall make recommendations to the 2026 AGM regarding:
- Election of the Chair of the 2026 AGM
- Remuneration of the members of the Board of Directors, distinguishing between the Chair and other members, and remuneration for Board Committee work
- Election of members of the Board of Directors, including number of members
- Election of the Chair of the Board of Directors
- Remuneration of the auditor
- Election of the auditor
- Nomination Committee Process for the 2027 AGM, if any amendments are proposed to the Process for the 2026 AGM
Shareholders who wish to present a motion to the Nomination Committee regarding the above-mentioned matters, should contact the Chair of the Nomination Committee, Aksel Azrac, at nomcom@orron.com no later than 19 December 2025.
For further information, please contact:
Robert Eriksson
Corporate Affairs and Investor Relations
Tel: +46 701 11 26 15
robert.eriksson@orron.com
Jenny Sandström
Communications Lead
Tel: +41 79 431 63 68
jenny.sandstrom@orron.com
Orrön Energy is an independent, publicly listed (Nasdaq Stockholm: “ORRON”) renewable energy company within the Lundin Group of Companies. Orrön Energy’s core portfolio consists of high quality, cash flow generating assets in the Nordics, coupled with greenfield growth opportunities in the Nordics and Europe. With significant financial capacity to fund further growth and acquisitions, and backed by a major shareholder, management and Board with a proven track record of investing into, leading and growing highly successful businesses, Orrön Energy is in a unique position to create shareholder value through the energy transition.
Forward-looking statements
Statements in this press release relating to any future status or circumstances, including statements regarding future performance, growth and other trend projections, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipate”, “believe”, “expect”, “intend”, “plan”, “seek”, “will”, “would” or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that could occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to several factors, many of which are outside the company’s control. Any forward-looking statements in this press release speak only as of the date on which the statements are made and the company has no obligation (and undertakes no obligation) to update or revise any of them, whether as a result of new information, future events or otherwise.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S6.11.2025 19:00:56 CET | Press release
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
BONDUELLE6.11.2025 18:00:00 CET | Press release
BONDUELLE - Quarter 1 FY 2025-2026 Sales: The Bonduelle Group confirms its resilience in a demanding environment
Verkkokauppa.com Oyj6.11.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
Vivoryon Therapeutics N.V.6.11.2025 17:31:00 CET | Press release
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
Aspo Plc6.11.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 6.11.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom